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Abstract
This article introduces Targeted Smooth Bayesian Causal Forests, or tsbcf, a semi-
parametric Bayesian approach for estimating heterogeneous treatment effects which
vary smoothly over a single covariate in the observational data setting. The tsbcf
method induces smoothness in estimated treamtent effects over the target covariate by
parameterizing each tree’s terminal nodes with smooth functions. The model allows
for separate regularization of treatement effects versus prognostic effect of control
covariates; this approach informatively shrinks towards homogeneity while avoiding
biased treatment effect estimates. We provide smoothing parameters for prognostic
and treatment effects which can be chosen to reflect prior knowledge or tuned in a
data-dependent way.
We apply tsbcf to early medical abortion outcomes data from British Pregnancy
Advisory Service. Our aim is to assess relative effectiveness of simultaneous versus
interval administration of mifepristone and misoprostol over the first nine weeks of
gestation, where we define successful outcome as complete abortion requiring neither
surgical evacuation nor continuing pregnancy. We expect the relative effectiveness of
simultaneous administration to vary smoothly over gestational age, but not necessar-
ily other covariates, and our model reflects this. We demonstrate the performance of
the tsbcf method on benchmarking experiments. The R package tsbcf implements our
method.
Keywords and phrases: Bayesian additive regression tree, causal inference, regular-
ization, Gaussian process, heterogeneous treatment effects
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1 Introduction
Home use of mifepristone and misoprostol to induce abortion in the first nine weeks of
gestation is safe and preferable to women over use in the clinic setting (Gold and Chong,
2015; Ngo et al., 2011). However, in England and Wales, the law does not permit use of
abortion medications outside of registered medical facilities (Abortion Act, 1967 (c.87).
The current recommended regimen for medical abortion up to 63 days of gestation in
Britain is 200 mg oral mifepristone followed by 800 micrograms vaginal misoprostol 24-
48 hours later (of Obstetricians and Gynaecologists, 2011). This ‘’inverval” protocol re-
quires a minimum of two clinic visits, which imposes financial and logistical burdens on
women’s access to medical abortion. Prior research shows that simultaneous dosing of
mifepristone and misoprostol is on average 97% as effective as interval administration
and is strongly preferred by women (Lohr et al., 2018). British Pregnancy Advisory Ser-
vices, a non-profit abortion provider with 60 clinics in England and Wales, introduced
the option of in-clinic simultaneous dosing in 2015. In the absence of legal home use,
simultaneous dosing reduces barriers to access.
Patients choose which regimen they prefer, and practitioners must provide guidance
which balances relative effectiveness of the two regimens versus accessibility. A key clini-
cal question is whether the relative effectiveness for simultaneous versus interval admin-
istration varies at later gestational ages, for specific subgroups of women, or a combina-
tion. Previous work uses logistic regression with propensity score quintiles to adjust for
self-selection to treatment protocol, and considers gestation discretized by weeks seven
and earlier, week eight, and week nine (Lohr et al., 2018). While this analysis did not find
signifant decreases in relative effectiveness as gestation advanced, it did not allow for
smooth change in effectiveness over gestation, nor does it allow for nuanced subgroup
analysis and careful regularization of heterogeneous treatment effects.
Let function f(t, x, z) represent the probability of successfully early medical abortion
occuring at gestational age t (in half-weeks), for a patient with maternal covariates x,
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who selected regimen z. Let z = 1 be the ‘’treatment”, or simultaneous, and z = 0 be the
‘’control”, or interval, regimens. We write this function as the sum of prognostic effect and
treatment effect, f(t, x, z) = µ(t, x) + τ(t, x)z. The first goal of this paper is to formulate
a model which provides better estimates of τ(t, x), when τ(t, x) evolves smoothly over t
but not necessarily x, where the model is carefully regularized to provide unbiased causal
estimates for observational data.
The second goal is to apply this model to the early medical abortion data to provide
clinicians with accurate, smooth estimates of relative effectiveness over gestation for in-
dividual patients and clinically relevant subgroups. This work fills an important gap in
ability to assess the relative effectiveness of early medical abortion regimens over time.
Current literature does not provide a way to characterize this function which allows for
smooth evolution of the treatment effect as gestation progresses. In addition, while clin-
icians expect that relative effectiveness should evolve smoothly over gestation, there is
not strong prior knowledge regarding potential heterogeneity in treatment groups and
how that heterogeneity may change over gestation. We apply our model to data from the
British Pregnancy Advisory Service to estimate τ(t, x), providing clinicians with smooth
estimates of relative effectiveness over gestation for both individuals, as well as condi-
tional average relative effectiveness estimates for subgroups of patients.
To estimate heterogeneous treamtent effects which evolve smoothly over a target co-
variate (gestation), we propose a new ensemble-of-trees model called Targeted Smooth
Bayesian Causal Forests. Our approach is based on the very successful Bayesian Addi-
tive Regression Trees (BART) model, introduced by Chipman et al. (2010). Our approach
is based on the very successful Bayesian Additive Regression Trees (BART) model, intro-
duced by Chipman et al. (2010). The BART model is a Bayesian tree ensemble model for
regression, which predicts scalar response y as the sum of binary regression trees over co-
variates x. Trees are regularized by a prior to be ‘’weak learners”, i.e. to be shallow with
relatively few splits, to avoid overfitting. Our model leverages two BART extensions: the
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BART with Targeted Smoothing (tsBART) framework of Starling et al. (2019) and the care-
fully regularized Bayesian Causal Forests (bcf) model of Hahn et al. (2017). BART with
Targeted Smoothing adapts the BART framework to induce smoothness over a single tar-
get covariate, and has been shown to outperform regular BART in when the underlying
regression function is in fact smooth over this covariate. Bayesian Causal Forests adapts
the BART framework to predict heterogeneous treatment effects, and regularizes the prior
to avoid biased treatment effect estimation. Motivated by modeling relative effectiveness
of early medical abortion regiments over gestation, our tsbcf model builds on the BART
framework, extending both aforementioned models in order to model smooth heteroge-
neous treatment effects for observational data.
In Section 2 we provide an overview of the early medical abortion regimens and the
dataset. Section 3 details the tsbcf model and reviews relevant work. Section 4 presents
results of a simulation study showing the advantages of tsbcf for several clinically rel-
evant treatment effect scenarios. Section 5 presents results of the early medical abortion
analysis using the tsbcf method. Section 6 contains discussion. Section 7 provides supple-
mental materials; the R package tsbcf implements our method. The Appendix provides
additional detail on fitting the tsbcf model.
2 Early Medical Abortion Regimens
2.1 Background.
Mifepristone and misoprostol are used together to induce medical abortion through the
ninth week of gestation. The recommended regimen for early medical abortion in Britain
is 200 mg oral mifepristone, followed by 800 micrograms vaginal misorprostol 24-48
hours later (of Obstetricians and Gynaecologists, 2011). This ‘’inverval” protocol re-
quires a minimum of two clinic visits, which imposes financial and logistical burdens
on women’s access to medical abortion. British Pregnancy Advisory Services, a non-
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profit abortion provider with 60 clinics in England and Wales, introduced the option of
in-clinic simultaneous dosing in 2015; in this regimen, mifepristone and misoprostol are
administered in a single clinic visit. Simultaneous dosing of mifepristone and misopros-
tol has been shown to be 97% as effective on average as interval administration, and is
strongly preferable; 85% of the women observed chose simultaneous over interval (Lohr
et al., 2018). Simultaneous dosing eliminates the need for a second clinic visit, reducing
barriers to access.
Patients select which protocol to undertake, and depend on clinicians’ guidance as
to the relative effectiveness of each choice. Knowledge of whether there is any change
in relative effectiveness as gestation progresses, and whether there are subgroups of pa-
tients who should be counseled differently, allows clinicians to provide more accurate
and personalized information to their patients. Uncertainty quantification is also a key
component of providing patients with comprehensive guidance.
Previous research (Lohr et al., 2018) investigates whether relative effectiveness de-
creases at later gestational ages, and does not find evidence of a significant drop in effec-
tiveness for simultaneous versus interval dosing as gestational age increases. This work
uses a logistic regression model with gestational age groups and propensity score quin-
tiles as covariates; gestational age is discretized into 49 days or less, 50-56 days, and 57-63
days. A limitation of this model is the discretization of gestation, as the model does not
provide a smooth estimate of the impact of gestational age progress on relative effective-
ness. A second limitation is that while inclusion of propensity score estimates may help
adjust for biased treatment effect estimates due to self-assignment, the model lacks regu-
larization to reduce bias in the presence of potential targeted selection (Hahn et al., 2018).
This model does not allow for exploration of subgroups or nuanced estimation of indi-
vidual treatment effects over gestation. Our model improves on this previous approach
with careful regularization, uncertainty quantification, smoothness over gestational age,
and estimates of both subgroup and individual-level relative effectiveness estimates.
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2.2 Data description.
We use observational data from early medical abortions provided at British Pregnancy
Advisory Service clinics from May 1, 2015 to April 30, 2016. Data was collected from
British Pregnancy Advisory Service’s electronic booking and invoicing system, which
contains records of services provided to clients, including selected demographic and clin-
ical characteristics. These data are initially entered by telephone operators at British Preg-
nancy Advisory Service’s telephone contact center; details are then validated by clin-
icians at both in-person consultations and at treatment appointments. Complications
and adverse outcomes are identified during post-treatment follow-up visits, or British
Pregnancy Advisory Services is notified by other providers or by women themselves.
When possible, hospital discharge summaries or documents from general practitioners
are obtained to confirm outcomes. Staff cross-check the booking and invoicing system
for any appointments with British Pregnancy Advisory Services after the date of treat-
ment, and hand-check medical records if a continuing pregnancy or incomplete abortion
was recorded in the complications database. This study was approved and exempted
from full human subjects review by British Pregnancy Advisory Services and The Uni-
versity of Texas at Austin since all data were pre-existing and were provided in a fully
de-identified format.
The dataset consists of 28,895 independent patient records. The sample consists of
women with pregnancies of between 4.5 weeks (32 days) 9 weeks (63 days) gestation or
less as determined by abdominal or vaginal ulstrasonography, who wanted a medical
abortion, and who had no contraindications. Early medical abortion is available through
9 weeks of gestation. While 4 weeks is typically the earliest a patient is aware of the
pregnancy, only 12 women obtained early meidcal abortions below 4.5 weeks; our ana-
lytic sample begins at 4.5 weeks. Women were offered the choice between 200 mg oral
mifepristone followed by 800 micrograms vaginal misoprostol within 15 minutes (simul-
taneous administration), or 24-72 hours later. Women chose their preferred regimen after
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being informed of expected differences in side effects and outcomes. Our analytic sam-
ple consists of women who chose simultaneous dosing or a 24-48 hour interval between
medications.
The binary response is a successful early medical abortion outcome, defined as com-
plete expulsion of uterine contents after early medical abortion, without surgical interven-
tion and without continuing pregnancy, as defined by the Medical Abortion Reporting of
Efficacy Guidelines Creinin and Chen (2016). Women could choose to return two weeks
post-treatment for a vaginal ultrasound, or could use a low-sensitivity urine pregnancy
test (detection limit 1,000 international units human chorionic gonadotrophin) and symp-
tom checklist to self-report the outcome of the abortion (Cameron et al., 2015). Women
could schedule a clinic visit at any time to address concerns or symptoms of a possible
complication, including continuing pregnancy. Women diagnosed at a follow-up visit
with a retained nonviable sac or embryo were offered the choice of another 800 micro-
grams vaginal mifepristone or surgical evacuation, and women diagnosed with contin-
ued pregnancy were offered surgical evacuation; all of these are considered unsuccessful
procedures.
3 Targeted Smooth Bayesian Causal Forests
Targeted Smooth Bayesian Causal Forests (tsbcf) offers a promising technique for es-
timating relative effectiveness of simultaneous versus interval administration of mifepri-
stone and misoprostol. Suppose that xi represents available covariates for patient i: ma-
ternal age (years), Body Mass Index (kg/m2), maternal ethnicity (Asian, Black, Other,
Not Reported, white), and the numbers of previous abortions, births, Cesarean sections,
and miscarriages. Let ti represent the gestational age at which early medical abortion
occurred, in discrete half-week milestones ranging from 4.5 (32 days) to 9 (63 days).
We begin by briefly reviewing the original BART framework on which our method is
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Characteristic (N = 28,895) Interval: (N = 4,354) Simultaneous: (N = 24,541) P-value
Gestational age in weeks, n (%) < 0.0001
4.5 407 (1.41) 20 (0.46) 387 (1.58)
5-5.5 4,917 (17.02) 531 (12.20) 4,386 (17.87)
6-6.5 9,453 (32.72) 1,244 (28.57) 8,209 (33.45)
7-7.5 7,875 (27.25) 1,368 (31.42) 6,507 (26.51)
8-8.5 5,577 (19.30) 1,019 (23.40) 4,558 (18.57)
9 666 (2.30) 172 (3.95) 494 (2.01)
Maternal age in years, n (%) = 0.0001
(11,20] 5,312 (18.38) 888 (20.40) 4,424 (18.03)
(20,30] 15,010 (51.95) 2,178 (50.02) 12,832 (52.29)
(30,40] 7,695 (26.63) 1,181 (27.12) 6,514 (26.54)
(40,53] 878 (3.04) 107 (2.46) 771 (3.14)
Maternal ethnicity, n (%) < 0.0001
Asian 2,610 (9.03) 510 (11.71) 2,100 (8.56)
Black 1,839 (6.36) 310 (7.12) 1,529 (6.23)
Not Reported 537 (1.86) 64 (1.47) 473 (1.93)
Other 1,568 (5.43) 247 (5.67) 1,321 (5.38)
White 22,341 (77.32) 3,223 (74.02) 19,118 (77.90)
BMI, n (%) = 0.5364
Underweight (<18.5) 2,149 (7.44) 329 (7.56) 1,820 (7.42)
Normal (18.5-24.9) 14,667 (50.76) 2,209 (50.73) 12,458 (50.76)
Overweight (25.0-29.9) 7,367 (25.50) 1,080 (24.80) 6,287 (25.62)
Obese (>30.0) 4,712 (16.31) 736 (16.90) 3,976 (16.20)
Previous abortions, n (%) < 0.0001
0 18,354 (63.52) 2,949 (67.73) 15,405 (62.77)
1-2 9,876 (34.18) 1,301 (29.88) 8,575 (34.94)
3+ 665 (2.30) 104 (2.39) 561 (2.29)
Previous births, n (%) < 0.0001
0 18,354 (63.52) 2,949 (67.73) 15,405 (62.77)
1-2 5,070 (17.55) 609 (13.99) 4,461 (18.18)
3+ 5,471 (18.93) 796 (18.28) 4,675 (19.05)
Previous Cesarean sections, n (%) < 0.0001
0 18,354 (63.52) 2,949 (67.73) 15,405 (62.77)
1-2 1,346 (4.66) 169 (3.88) 1,177 (4.80)
3+ 9,195 (31.82) 1,236 (28.39) 7,959 (32.43)
Previous miscarriages: < 0.0001
0 18,354 (63.52) 2,949 (67.73) 15,405 (62.77)
1-2 2,046 (7.08) 264 (6.06) 1,782 (7.26)
3+ 8,495 (29.40) 1,141 (26.21) 7,354 (29.97)
Table 1: Descriptive characteristics of women choosing simultaneous or interval admin-
istration of mifepristone and misoprostol for early medical abortion. Patients obtained
early medical abortion from May 1, 2015 to April 30, 2016 at British Pregnancy Advi-
sory Service clinics. P-values test for differences in distribution of patient characteristics
between the simultaneous and interval groups using chi-squared tests.
based (Chipman et al., 2010). We then review BART with Targeted Smoothing (Starling
et al., 2019) and Bayesian Causal Forests (Hahn et al., 2017), the two BART extensions we
leverage in development of our model. We then introduce our Targeted Smooth Bayesian Causal Forests
method, discuss model assumptions and modeling a binary response, followed by a re-
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view of relevant literature.
3.1 The BART model.
We begin by reviewing the original Bayesian Additive Regression Trees (BART) model.
BART is a Bayesian tree ensemble model for regression, known for accurate prediction
while avoiding specification of a parametric model formulation. BART models an un-
known function f(x) as the sum of piecewise constant binary regression trees (Figure 1,
Left and Middle). The BART model is defined by a likelihood and prior. Each tree Tl,
1 ≤ l ≤ L, consists of a set of internal decision nodes which partition the covariate space
(A1, . . . , ABl); each partition element Ab is associated with a terminal node value mlb.
The partition and leaves define a piecewise constant function, gl(x) = mlb∀x ∈ Ab.
Each of the L regression trees are additively combined into a single estimate f(x) =∑n
l=1 gl(x). The BART prior constrains the gl functions to favor small trees and leaf param-
eters that are close to zero; in this way, trees are ‘’weak” learners, regularizing BART to
avoid overfitting. Each tree independently follows the prior described in Chipman et al.
(2010), where probability that a node splits at depth h is given by η (1 + h)−β where η ∈
(0, 1) and β ∈ [0, inf). The leaf parameters are given independent priors mlb ∼ N(0, σ2m)
with σm = σ0/
√
L.
Chipman et al. (2010) suggest letting η = 0.95 and β = 2 to put low probability on
deep trees with many splits. They also suggest using σ0 to calibrate the possible range of
estimated f(x) values, as the induced marginal prior of f(x) is centered at zero with ap-
proximately 95% of the prior mass ±2σ0. Model fitting is accomplished using an MCMC
Bayesian Backfitting algorithm; we refer readers to the original paper for full details.
BART has been successful in a variety of contexts including prediction and classifica-
tion (Chipman et al., 2010; Murray, 2017; Linero and Yang, 2017; Linero, 2018; Herna´ndez
et al., 2018), survival analysis (Sparapani et al., 2016; Starling et al., 2019), and causal
inference (Hill, 2011; Hahn et al., 2017; Logan et al., 2017; Sivaganesan et al., 2017).
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x1 < 0.9
µ1j x2 < 0.4
µ2j µ3j
no yes
no yes
0.4
0.9
x1
x2 µ1j
µ2j
µ3j
x1 < 0.9
µ1j(t)
x2 < 0.4
µ2j(t) µ3j(t)
no yes
no yes
Figure 1: (Left) An example binary tree Tj where terminal nodes are labeled with the
corresponding scalar parameters µhj . (Middle) The corresponding partition of the sample
space and the step function g(Tj,Mj). (Right) BART with Targeted Smoothing where the
µhj(t) parameters associated to terminal nodes are now functions of time t.
3.2 BART with Targeted Smoothing
The BART model is known for excellent predictive performance but lacks smoothness.
Starling et al. (2019) introduce a method called BART with Targeted Smoothing (tsBART)
for regression that is smooth in some covariate t; the scalar node-level parameters mhj are
replaced with univariate functions mhj(t) and assigned a Gaussian Process prior with a
squared-exponential covariance function. Figure 1 (Right) illustrates a single example tree
with targeted smoothing. The model formulation for tsBART is similar to BART, except
that the estimand f(t, x) is now explicitly a function of covariates and the target covariate.
Observations consist of (yi, ti, xi) where xi is the vector of unsmoothed covariates and ti
is the value of the target covariate. Then the model is formulated as
yi = f(ti, xi) + i, i ∼ N(0, σ) (1)
f(ti, xi) =
m∑
j=1
gj(ti, xi;Tj,Mj) . (2)
The BART with Targeted Smoothing model is fit using intuitive extensions to the
Bayesian Backfitting detailed in Chipman et al. (2010), and requires an additional param-
eter specification: κ, a smoothness parameter, regulates the lengthscale of the Gaussian
Process prior. Starling et al. (2019) provide an intuitive default and tuning suggestions
for this parameter, while other parameter settings mirror the original BART method.
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3.3 Bayesian Causal Forests
Bayesian Causal Forests (bcf) extends the BART framework to estimate heterogeneous
treatment effects for observational data (Hahn et al., 2017). Let x represent covariates, and
z a binary treatment indicator. Then bcf models response surface f(x, z) as the sum of two
functions: a function modeling prognostic impact of control covariates, representing the
component of the mean response unrelated to treatment effect, and a second representing
the trreatment effect directly. The two functison are modeled as separate tree ensembles
with their own BART priors, allowing for separate regularization of the treatment effect
estimate. This approach allows treatment effect priors to shrink towards homogeneous
treatment effects.
The bcf model specifies that the prognostic BART fit includes propensity score esti-
mates as a covariate to improve treatment effect estimation in the presence of confound-
ing. Improvement is particularly pronounced when confounding is due to targeted se-
lection, in which individuals select the treatment protocol based on predictions of the
potential outcomes (Hahn et al., 2018).
Observations consist of (yi, zi, xi), where yi indicates response, zi binary treatment, and
xi is the vector of covariates. Let pˆi(xi) be estimates of the propensity score P (zi = 1 | xi).
The bcf model is formulated as
yi = f(xi, zi) + i, i ∼ N(0, σ2) (3)
f(xi, zi) = µ (xi, pˆi (xi)) + τ (xi) zi (4)
where µ and τ are the prognostic and treatment BART fits. The goal is estimating con-
ditional average treatment effects (CATE) – the amount by which response yi differs in
the cases where zi = 1 versus zi = 0, notated using the counterfactual outcomes frame-
work of Imbens and Rubin (2015) where yi(0) and yi(1) denote potential outcomes under
control versus treatment. In this framework, observations correspond to realized trea-
11
ments, such that yi = ziyi(1) + (1− zi) yi(0). Then the causal estimand is expressed as
τ(xi) = f(xi, zi = 1)− f(xi, zi = 0).
The bcf model has desirable qualities for modeling relative effectiveness of early med-
ical abortion protocols. We could include gestational age in the covariate vector x. How-
ever, bcf lacks any mechnanism to induce smoothness over gestational age, consistent
with clinical intuition.
3.4 Targeted Smooth Bayesian Causal Forests
Let y denote a scalar response, and z a binary treatment indicator. Let x denote a p-
length vector of observed control variables, and t a scalar target variable over which we
wish to induce smoothness. Consider an observed sample of independent observations
(yi, ti, zi, xi) for i ∈ {1, . . . , n}. We introduce Targeted Smooth Bayesian Causal Forests
(tsbcf), a method which leverages the frameworks of tsBART and bcf to model heteroge-
neous treatment effects which vary smoothly over t while providing appropriate regular-
ization to avoid biased treatment effect estimates.
We restrict to the mean-zero additive error setting
yi = f(ti, xi, zi) + i, epsiloni ∼ N(0, σ2) (5)
such that E(yi | ti, xi, zi) = f(ti, xi, zi) and the treatment effect of letting zi = 1 versus
zi = 0 is equivalent to
τ(ti, xi) = f(ti, xi, , 1)− f(ti, xi, 0) (6)
We then model the response surface E(yi | ti, xi, zi) = f(ti, xi, zi) as
f(ti, xi, zi) = µ (ti, xi, pˆii) + τ (ti, xi, ) zi (7)
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which allows for direct specification of a prior over the treatment effects. We also include
the estimated propensity score in the estimation of the prognostic effect. We use variants
of the tsBART prior to model µ and τ .
To model µ, we use the default tsBART prior with 200 trees, depth penalty β = 2,
splitting probability η = 0.95, and smoothing parameter κµ = 1, with a half-Cauchy prior
on the scale of leaf parameters (Gelman, 2006; Starling et al., 2019). For modeling τ , we
prefer the tsBART prior to have stronger regularization to reflect our belief that treatment
effect heterogeneity is generally simple over covariates and time. We let κτ = 1 to reflect
heterogeneity over t. We use 50 trees and set β = 3 and splitting probability η = 0.25 to
shrink towards homogeneity in x. We replace the half-Cauchy prior with a half-Normal
prior on the scale of the leaves, with median set to the marginal standard deviation of y.
We assign σ2 an inverse chi-squared prior, σ2 ∼ νλ/χ2ν . See Appendix A1 for full
model specification, including data augmentation to induce the half-Cauchy and half-
Normal priors on the respective scales. See Appendix A2 for details on model fitting; we
fit the model using updates to the Bayesian Backfitting algorithms for tsBART and bcf.
Starling et al. recommend WAIC-based tuning approaches for the tsBART smoothing
parameter κ, and similar tuning may be undertaken here in conjunction with intuition
and prior knowledge about the likely form of heterogeneity in the treatment effect.
3.5 Assumptions
Throughout the paper, we make the stable unit treatment value (SUTVA) assumption,
which excludes interference between units and multiple versions of treatment (Imbens
and Rubin, 2015). We also assume that strong ignorability holds, which stipulates that
there is no unmeasured confounding so that
yi(0), yi(1) |= zi | xi (8)
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and there is sufficient overlap to estimate treatment effects everywhere in covariate space
such that
0 < P ((zi = 1 | xi)) < 1 (9)
for all i ∈ 1, . . . , n observations.
3.6 Modeling a Binary Response
In the original BART paper, Chipman et al. (2010) provide a probit version of the BART
model for binary outcomes Y ∈ {0, 1}.
Pr(Y = 1 | x) = Φ (G (x)) (10)
G (x) =
m∑
j=1
g (x;Tj,Mj) (11)
where Φ is the standard normal CDF and G(x) is the standard BART model. Inference
is accomplished via data augmentation using the method of Albert and Chib (1993). The
tsBART method may be similarly augmented.
The tsbcf model can be extended in the same way for the binary early medical abortion
outcomes. Let ci be the observed binary response for i ∈ {1, . . . , n}, with target covariate
ti, treatment indicator zi, and vector of covariates xi. Let yi be the Gaussian latent variable,
then similar to the original BART model, we write our model as follows. Let
ci =

1 if yi ≥ 0
0 if yi < 0
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such that P (ci = 1 | ti, xi) = Φ (yi), where
yi = µ(ti, xi, pˆi) + τ(ti, xi, pii)zi + , i ∼ N(0, 1) (12)
Counterfactual probabilities of success are
ωi(0) = Φ (µ(ti, xi, pii)) (13)
ωi(1) = Φ (µ(ti, xi, pii) + τ(ti, xi)) (14)
so for observation i, causal estimands are expressed on the probability scale as
Absolute Risk Reduction: ∆i = ωi(1)− ωi(0) (15)
Relative Risk: RRi = ωi(1)/ωi(0) (16)
Number Needed to Treat: NNTi = 1/∆i. (17)
We include propensity score estimates and covariate vector xi in estimation of prog-
nostic effects. We refer readers to Rosenbaum and Rubin (1983); Hahn et al. (2017) for
a detailed discussion of reasons for including both; briefly, inclusion of propensity score
is an effective dimension-reduction technique which yields a prior that flexibly adapts
to complex patterns of confounding, and control covariates (instead of only propensity
score) are necessary for identifying heterogeneous treatment effects, particularly when
we do not believe that the response depends on covariates x strictly through the propen-
sity score.
3.7 Connection with existing work.
Our paper builds on several other extensions to the Bayesian tree-modeling framework.
We leverage two papers in particular in formulating the tsbcf model. The first is Hahn
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et al. (2017), who propose the Bayesian Causal Forest (bcf) model. Their model esti-
mates heterogeneous treatment effects from observational data using the BART frame-
work, with separately regularized BART priors for prognostic and treatment effects. This
approach allows for separate regularization of the treatment effect, allowing for shrink-
ing towards homogeneity. Their method is particularly careful in handling two closely
related phenomenon: targeted selection and regularization induced confounding.
Targeted selection occurs when selection into treatment is based in part on expected
outcomes under control, µ(t, x), where the probability of treatment is generally increasing
or decreasing as some function of this estimate. (This implies some functional relation-
ship between propensity scores pi and expected outcomes under treatment µ.) This seems
a likely scenario in the early medical abortion case, where clinicians may be likely to
caution patients they percieve as high-risk more strongly about potential decrease in ef-
fectiveness of the simultaneous regimen. Additionally, for accessibility reasons, clinicians
may provide more conservative advice to patients at more advanced gestational ages.
Estimation of treatment effects is complex because the minimal set of control vari-
ables is generally never known, and there are often many candidate control variables.
Regularization therefore plays a key role in accurate treatment effect estimation, but in
settings with confounding and modest treatment effects, biased treatment effects can oc-
cur if regularization is not performed carefully. Hahn et al. (2018) calls this phenomenon
‘’regularization-induced confounding” (RIC); we refer interested readers to their paper
and Hahn et al. (2017) for a full discussion. Briefly, RIC characterizes the tendency of
regularization priors to over-shrink control variable estimates, which adversely biases
treatment effect estimates. The bcf method’s careful specification of regularization priors
avoids this phenomenon, and our tsbcf method similarly guards against this bias.
For inducing smoothness in a target covariate, we build on the BART with Targeted
Smoothing (tsBART) method (Starling et al., 2019), which replaces trees’ scalar leaf param-
eters with smooth functions over the target covariate and assigns Gaussian Process priors
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over the discrete grid of target covariate values for smoothing. The degree of smoothness
is regulated via tuning parameter κ (default value 1) which regulates the lengthscale of
the covariance. Our method also uses the Gaussian Process prior to induce smoothness,
but allows for separate regularization of the degree smoothness for the prognostic and
treatment estimates.
We refer interested readers to Chipman et al. (2010) for a detailed review of the original
BART method. Other work has been done on smooth versions of BART, notably Linero
and Yang (2017). Linero et al. propose smoothing a regression tree ensemble by random-
izing the decision rules at internal nodes of the tree. This model induces smoothness over
all covariates by effectively replacing the step function induced by the binary trees with
sigmoids, instead of smoothing over one targeted covariate.
4 Simulations
We compare tsbcf to several existing models in a benchmarking study designed to
simulate five clinically plausible treatment effect scenarios. We generate prognostic ef-
fects, treatment effects, and random noise for each scenario, and assess how well each
model recovers the treatment effects. We compare the following models.
• bcf: The Bayesian Causal Forest model described in Hahn et al. (2017). We expect
this model to perform well but lack smoothness (Figure 7).
• hillbart: Ordinary BART used to model the response surface in the causal inference
setting (Hill, 2011).
• lm: A linear model of the form Y = Xβ+ZXαwhere design matricesX include the
target covariate, all other covariates, and two- and three-way interactions between
all predictors, including the target covariate.
• psbart: Ordinary BART with estimated propensity scores included as a covariate
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(Rosenbaum and Rubin, 1983).
• splines: A linear model with cubic B-splines with 7 degrees of freedom model-
ing the target covariate, and two- and three-way interactions among all predictors,
including the target covariate splines.
• tsbcf default: The tsbcf method, with smoothing parameters κµ = 1 and κτ = 1.
• tsbcf wiggly: The tsbcf method, with smoothing parameters κµ = 1 and κτ = 3.
Simulated data is generated as follows. For independent observations i ∈ {1, . . . . , n},
draw a vector of covariates xi = {x1i, x2i, x3i, x4i, x5i} iid∼ N(0, 1) and draw target covariate
ti ∈ {0.1, 0.2, . . . . , 1}. Each observation is assigned to treatment (zi = 1) or control (zi = 0)
based a binomial draw with propensity score
pii = Φ
(
ρ ·
[x1i
6
− x2i
4
]
+ (1− ρ) [−1 (x4i > 5 + 1(x4i < 5))]
)
(18)
where ρ ∈ [0, 1] controls the amount of targeted selection; ρ controls the degree to which
the propensity score is based on a somewhat accurate prediction of the potential outcome,
since
[
x1i
6
− x2i
4
]
is found in the prognostic effect (Equation 20), while x4i and x5i are not
used in prognostic or treatment effect generation. We generate estimates for the propen-
sity scores pˆii using the dbarts R package (Chipman et al., 2010); any accurate prediction
is viable, as in Hahn et al. (2017).
We then generate observations as
yi = µ(ti, x1i, x2i) + τ(ti, x3i)zi + i, i ∼ N(0, σ2) (19)
where µ is the prognostic function and τ is the treatment effect function. The prognostic
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function is the same for all five scenarios:
µ(ti, x1i, x2i) = 8 +
3
4
ti +
x1i
6
+
x2i
4
(20)
We vary τ(ti, xi) by scenario, reflecting different treatment effects as follows.
• Scenario A represents a treatment effect that varies smoothly over the target covari-
ate t, with homogeneity in x.
τ(ti, xi) = 2.5 + 0.75ti − 0.05 sin(2piti)
• Scenario B represents heterogeneous treatment effects that vary smoothly over t
with modest differences in subgroups.
τ(ti, xi) = 2.5 + 1.5I (x3i > −1/2) + 1.5I (x3i > 1/2) + 0.75ti − 0.05 sin(2piti)
• Scenario C represents heterogeneous treatment effects, similar to Scenario B except
that the effects of t and x are inseparable.
τ(ti, xi) = 2.5 + 1.5I (x3i > −1/2) + (1.5 + 0.375ti) I (x3i > 1/2) + 0.375ti − 0.05 sin(2piti)
• Scenario D gives heterogeneous treatment effects with small effects in general, ex-
cept for a small subgroup with a pronounced effect.
τ(ti, xi) = 0.5 + 0.05I (x3i > −1/2) + 2.5I (x3i > 1/2) + 0.75ti − 0.05 sin(2piti)
• Scenario E is a constant treatment effect, requiring shrinking to homogeneity in both
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x and t.
τ(ti, x3i) = 3
Let σ2 = 1 for all scenarios. This setting scales treatment effects to be relatively modest
compared to prognostic effects (roughly a third of the magnitude), and scales random
noise appropriately to the size of the treatment effects.
Figure 2 illustrates the setup for our benchmarking simulation for a single simulated
dataset and provides motivation for the tsbcf method. The five columns represent each
scenario, with target covariate tgt on the x-axis, and the conditional average treatment
effect (CATE) on the y-axis. In each panel, the solid line(s) represent the ground truth
for each scenario’s treatment effects; a single line indicates homogeneity in covariates,
while multiple lines indicate heterogeneous subgroups. Dashed lines are posterior mean
CATE estimates, and shaded regions are 95% posterior credible intervals. While the bcf
estimates in the top row are generally good, they lack smoothness in the target covari-
ate, which motivates our method. The tsbcf estimates induce smoothness over the target
covariate without compromising the accuracy of the bcf estimates.
Figure 3 gives the average RMSE for recovering the CATE over the target covariate
for each model and scenario combination. RMSE is averaged over 100 replications of the
simulation, each consisting of generating a dataset and fitting each model. Each row rep-
resents a sample size, and each column is a scenario. Within each panel, lines give average
RMSE over the target covariate for each method; RMSE is calculated for each replication
at each target covariate value, and then the average is calculated across replicates. The
tsbcf model performs comparably to the bcf while inducing the desired smoothness that
we saw in Figure 2. Results confirm that we have successfully achived the goal to in-
duce smoothness while not compromising excellent performance. The linear and spline
models significantly underperform in scenarios with heterogeneous treatment effects.
20
Scenario A Scenario B Scenario C Scenario D Scenario E
bcf
tsbcf_default
0.1 0.5 10.1 0.5 10.1 0.5 10.1 0.5 10.1 0.5 1
0
2
4
6
0
2
4
6
Target covariate
CA
TE
Subgroup 1 Subgroup 2 Subgroup 3
Figure 2: This figure illustrates the setup for our benchmarking simulation and provides
motivation for the tsbcf method. We simulate five different clinically plausible treat-
ment effect scenarios. In each panel, the target covariate is on the x-axis and CATE is
on the y-axis. In each panel, the solid line(s) represent the ground truth for each sce-
nario’s treatment effects; a single line indicates homogeneity in covariates, while multi-
ple lines indicate heterogeneous subgroups. Dashed lines show posterior mean CATE
estimates and shaded regions give 95% posterior credible intervals. The top row shows
Bayesian Causal Forest (bcf) estimates for CATE; the bottom row gives estimates using
Targeted Smooth Bayesian Causal Forests (tsbcf) with default smoothness parameter set-
tings. While the bcf estimates are generally good, they lack smoothness in the target
covariate, which motivates our method. The tsbcf estimates induce smoothness over the
target covariate without compromising the accuracy of the bcf estimates.
We next focus on methods with smaller RMSE (Figure 3) and inspect RMSE for recov-
ering CATE in relation to coverage and interval length. Panel A gives coverage versus
RMSE; the lower-right corner of the plot gives the optimal frontier of low RMSE com-
bined with good coverage. All of the methods maintain approximately nominal (95%)
coverage, while the tsbcf methods have lower RMSE. The ‘’default” tsbcf outperforms
the ‘’wiggly” version here, as the true treatment effects are very smooth over the target
covariate; however, the ‘’wiggly” version is still outperforming other methods. Panel B
gives coverage versus interval length. Both tsbcf settings have slightly narrower inter-
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Figure 3: RMSE for recovering the conditional average treatment effects (CATE) for sub-
groups in each scenario across the target covariate. RMSE is averaged over 100 replicates
of the simulation, each consisting of generating a dataset and fitting the models. The
rows give results for two sample sizes. We compare several models; tsbcf default and
tsbcf wiggly are tsbcf with default (κµ = 1, κτ = 1) and less smooth (κµ = 1, κτ = 3)
settings. Both tsbcf models perform comparably to the bcf model while inducing the de-
sired smoothness. Results confirm that we have achived the goal to induce smoothness
while not compromising accurate heterogeneous treatment effect estimation. The linear
and spline model estimates are biased due to generation of the simulation with some con-
founding, to mimic realistic observational data scenarios; regular BART methods are less
robust to this confounding, while bcf and tsbcf are designed to be robust due to separate
regularization of the treatment tree fit.
vals than other methods, and bcf has slightly inflated variance due to lack of smoothness
over the target covariate. Panel C gives interval length versus RMSE, and tsbcf has both
shortest interval length and lowest RMSE, for both smoothness settings. Together, these
panels demonstrate that in scenarios where the underlying treatment effect is smooth over
the target covariate, tsbcf recovers the heterogeneous treatment effects while maintaining
coverage and yielding reasonable measures of uncertainty.
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Figure 4: Compares average RMSE, coverage, and interval length for each method. (A)
Coverage versus RMSE, where the lower-right frontier gives the optimal frontier of low
RMSE combined with good coverage. All methods maintain approximately nominal
(95%) coverage while the tsbcf methods have lower RMSE. The ‘’default” tsbcf outper-
forms the ‘’wiggly”, as the true treatment effects are very smooth over the target covari-
ate; however, the ‘’wiggly” version is still outperforming other methods. (B) Coverage
versus interval length. Both tsbcf settings have slightly narrower intervals than other
methods, and bcf has slightly inflated variance due to lack of inducing smoothness over
the target covariate. (C) Interval length versus RMSE, and tsbcf has both shortest inter-
val length and lowest RMSE for both smoothness settings. Together, these demonstrate
that in scenarios where the underlying treatment effect is smooth over the target covari-
ate, tsbcf recovers the heterogeneous treatment effects while maintaining coverage and
yielding reasonable measures of uncertainty.
5 Results for Early Medical Abortion Modeling
We now focus on our scientific problem, estimating relative effectiveness of simul-
taneous versus interval administration of mifepristone and misoprostol in early medical
abortion. We apply tsbcf to the British Pregnancy Advisory Services data described in Sec-
tion 2. We model the probability of successful early medical abortion across gestational
age, τ(t, x), using the probit extension of the tsbcf (Section 3.6). Our target covariate for
smoothing is gestational age in half-weeks, ti ∈ {4.5, 5, 5.5, . . . , 9}, where 4.5 indicates 32–
34 days gestation, 5 weeks indicates 35–38 days, 5.5 indicates 39–41 days, and so on. Let
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ci be a binary indicator for successful early medical abortion, and zi be a binary indicator
for simultaneous (zi = 1) versus interval (zi = 0) regimen. Let xi be the vector of patient
characteristics, including age in years, body mass index (kg/m2), maternal ethnicity, and
numbers of previous abortions, births, Cesarean sections, and miscarriages.
Our goal is to provide clinicians with a smooth estimate of relative effectiveness of si-
multaneous versus interval protocols across gestational age, to provide accurate advice to
women selecting a protocol. We are interested in knowing average relative effectiveness
across gestation, as well as whether there are subgroups of patients where relative effec-
tiveness over gestation differs. Relative effectiveness is calculated as the ratio between the
two counterfactual treatment effect estimates on the probability scale. Let yi be the pro-
bit latent variables as in Equation 12. Then the counterfactual probabilities of successful
emergency medical abortion are as defined in Equations 12 and 13, and causal estimands
relative risk and number needed to treat are as in Equation 15. We refer to relative risk
as ‘’relative effectiveness” of the simultaneous compared to interval protocol throughout
our work, as defining a ‘’risk” of successful procedure is not clinically intuitive; there is
no mathematical distinction.
For each MCMC iteration (b), we obtain a draw of ∆(b)i and RR
(b)
i for each patient at
each gestational age; we can then average across patients at each gestational age to obtain
each MCMC draw of the ∆ and RR for a given gestation, or average across subgroups of
patients to obtain MCMC draws of the ∆ and RR for that subgroup at a given gestation.
We summarize results by calculation posterior mean and 95% credible intervals at each
gestational age. For MCMC draws b ∈ {1, . . . , B},RR(b)i is the bth MCMC draw for relative
risk for individual iwho is observed at gestational age ti. Then we obtain posterior draws
of estimated relative effectiveness at some gestational age t as
RˆR
(b)
t =
∑
i|ti∈t
RˆR
(b)
i (21)
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then we use MCMC draws
{
RˆR
(1)
t , . . . , RˆR
(B)
t
}
to calculate the posterior mean and cred-
ible interval for RRt.
We fit the tsbcf model to the early medical abortion data and calculate posterior mean
relative effectiveness at each half-week of gestation. Mean posterior relative effectiveness
of 0.95 at some gestational age t is clinically interpreted as the simultaneous protocol be-
ing 95% as effective as the interval protocol on average at gestational age t. Figure 5,
panel A gives posterior mean relative effectiveness of the simultaneous versus interval
regimen, averaged across all women, as a function of gestational age. The solid line gives
the posterior mean relative effectiveness, and the shaded area reflects 95% posterior cred-
ible intervals across gestation. The slight kick-up and inflated credible intervals at nine
weeks gestation are a result of small sample size; women obtaining early medical abortion
in the ninth week of gestation account for only 2.3% of cases (Table 1).
Number needed to treat (NNT) gives the number of women who would need to be
treated under the simultaneous protocol instead of interval before one additional failed
procedure is observed than would occur under interval administration. Figure 5, panel B
gives the posterior mean NNT and 95% credible interval. While there is a slight decrease
in relative effectiveness as gestation advances, the average relative effectiveness remains
high over the course of gestation. We also note the large interval including zero at 4.5
weeks; the posterior relative risk is close to 1 here, with credible interval bounds falling
on each side of one, indicating that simultaneous and interval protocols are nearly equally
effective this early in gestation.
After averaging over the cohort, we aim to identify subgroups of women with het-
erogeneity in relative effectiveness. We take a ‘’fit-the-fit” approach to subgroup analysis
(Hahn et al., 2017) where we use individual relative effectiveness estimates are used as
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Figure 5: Mean relative effectiveness and number needed to treat for the cohort. (A) Pos-
terior mean relative effectiveness of the simultaneous versus interval regimen, averaged
across all women, across gestational age. The solid line gives the posterior mean relative
effectiveness, with shaded 95% credible intervals. We note the relatively small sample
size at 9 weeks, resulting in a slight kick-up that we do not believe is clinically relevant, as
well as inflated uncertainty (Table 1). (B) Posterior mean number needed to treat (NNT),
giving the average number of patients needed to receive treatment under the simultane-
ous regimen before one additional early medical abortion failure is observed compared
to failures under the interval regimen. While there is a slight decrease in relative effec-
tiveness as gestation advances, the average relative effectiveness remains high over the
course of gestation.
the response. Individual posterior mean relative effectiveness estimate are calculated as
RˆRi =
B∑
b=1
RˆR
(b)
i . (22)
To assess subgroup heterogeneity, we focus on women where gestational age is in
the 7–9 week range; this is the clinically interesting area of the posterior mean relative
effectiveness curve in Figure 5. The individual relative effectiveness estimates, RˆRi, for
women where ti ∈ 7, . . . , 9 are used as inputs to a CART model Chipman et al. (1998),
with xi as covariates.
Figure 6 gives the tree fit from the CART model. Each tree node in the figure contains
the posterior mean relative effectiveness and the percent of observations for that node.
In parenthesis below each terminal node is the NNT corresponding to the relative effec-
tiveness. Age, the first split, is the most important subgroup; patients 29 and older have
26
slightly lower relative effectiveness compared to their younger counterparts. Within the
older and younger cohorts, number of previous births also decreases relative effective-
ness, though slightly less so in the younger group of patients.
age >= 29
ethnicity = White,Not Reported,Other
prevBirth >= 2
age >= 22
prevBirth >= 1
0.95
100%
0.93
37%
0.93
30%
0.93
18%
0.94
12%
0.94
7%
0.96
63%
0.96
37%
0.95
19%
0.96
18%
0.97
26%
yes no
(15)             (17)             (17)             (25)             (25)             (34)
Figure 6: Tree from the ‘’fit-the-fit” CART model to investigate subgroups, where re-
sponse is individual relative effectiveness estimate, and covariates are patient charac-
teristics. Each node contains the posterior mean relative effectiveness and the percent of
observations contained in that split or terminal node. In parenthesis below each terminal
node is the NNT corresponding to that node’s relative effectiveness. Age is first split,
and so the most important subgroup; patients 29 and older see somewhat decreased rela-
tive effectiveness compared to their younger counterparts. Within the older and younger
groups of patients, number of previous births also decreases relative effectiveness, though
slightly less so in the younger group of patients.
The CART fit gives point estimates of mean posterior relative effectiveness for each
node. We query the posterior draws for subgroups at each level of the CART tree. Less
overlap in the posterior densities indicates meaningful splits. Concentration of the pos-
terior densities indicates more precisely isolated subgroups as a result of the tree split,
and more dispersion indicates greater heterogeneity within a tree split subgroup. Figure
7 plots the posteriors for various splits, moving down the tree. We refer to terminal nodes
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of this CART tree as Leaves 1 to 6, from left to right.
Panel A gives posteriors for the first split, on maternal age below 29. The lack of
overlap in the posterior relative effectiveness in older and younger women indicates a
substantive difference, with older women experiencing lower relative effectiveness than
their younger counterparts. Panel B gives posterior distributions for the younger cohort
(Leaves 4, 5, and 6). Leaf 4 includes patients ages 22 to 28 with no previous births. Leaf 5 is
comprised of patients ages 22 to 28 with one or more previous births, and Leaf 6 includes
patients 21 and younger. While there is some overlap between these three subgroups, the
posterior for Leaf 4 is noticeably lower than the others. Panel C gives posterior distribu-
tions for the second split on the left branch of the tree (splitting on maternal ethnicity).
Patients in Leaf 3 are Asian or Black, while patients in Leaves 1 and 2 are white or have
ethnicity of Other or Not Reported; all are age 29 or older. These groups do not appear
to be substantively different from each other. Panel D considers posteriors for all three
leaves on the left side of the tree. Women in Leaf 1 are 29 or older, ethnicity White, Not
Reported, or Other, and have two or more previous births. Women in Leaf 2 are same,
except for having one or no previous births. Women in Leaf 3 are Asian or Black. Women
in Leaf 1 have somewhat lower relative effectiveness than women in Leaves 2 and 3.
To summarize, age split at 29 is an important subgroup, with somewhat decreased
relative effectiveness in the older cohort. Within the younger and older cohorts, presence
of previous births had a slight negative impact on relative effectiveness, which was more
pronounced in patients 29 and older, less in patients 22–28, and not present in patients
under 22.
In order to get a better understand the difference in relative effectiveness between sub-
groups in terms of patient impact, Figure 8 gives a histogram of differences in subgroup
average NNT for women age 29 or older with ethnicity white, Other, or Not Reported,
and two or more previous births versus women under 22 (Leaf 6). These subgroups cor-
respond to comparing Leaf 1 and Leaf 6 of the CART tree (Figure 6). The histogram plots
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Figure 7: Posterior distributions of relative effectiveness for each CART tree split from
Figure 6. We reference terminal nodes 1 to 6, from left to right. Visualizing tree split
posteriors gives insight into magnitude of differences subgroups of patients. (A) Splits
on maternal age below 29. Lack of overlap in the posterior relative effectiveness in older
and younger women indicates a substantive difference in relative effectiveness. (B) Leaf
4 includes patients ages 22 to 28 with one or more previous births. Leaf 5 is comprised of
patients ages 22 to 28 with one or more previous births, and Leaf 6 includes patients 21
and younger. The posterior for Leaf 4 is somewhat lower than the others. (C) Splitting on
ethnicity in the older cohort. Patients in Leaf 3 are Asian or Black, while patients in Leaves
1 and 2 are white or have ethnicity of Other or Not Reported; all are age 29 or older. These
groups do not appear to be substantively different from each other. (D) PPosteriors for
all three leaves on the left side of the tree. Women in Leaf 1 appear to have somewhat
lower relative effectiveness than women in Leaves 2 and 3. In summary, age is the most
important covariate defining subgroups, with a split at age 29. Within each age group,
previous births decrease relative effectiveness slightly.
the distribution of subgroup average NNT difference for each MCMC draw. Differences
generally range from 20 to 60 patients, with no mass at zero, indicating that the difference
in these subgroups translates to real differences in number of women at later gestational
ages (7–9 weeks) who would need to receive the simultaneous protocol instead of interval
before seeing one additional failed procedure.
Figure 9 shows scatterplots of posterior mean relative effectiveness for individual
women, by age (panel A) and by number of previous births (panel B). Previous analy-
29
040
80
120
160
0 20 40 60 80
Difference in subgroup avg NNT
Fr
eq
ue
nc
y
Figure 8: Histogram of MCMC draws of differences in subgroup average NNT for women
age 29 or older, with ethnicity white, Other, or Not Reported, and two or more previous
births versus women under 22. These subgroups correspond to comparing Leaf 1 and
Leaf 6 of the CART tree (Figure 6). Differences generally range from 20 to 60 patients,
with no mass at zero, indicating that the difference in these subgroups translates to real
differences in number of women who would need to receive the simultaneous regimen
instead of interval before seeing an additional failed procedure.
sis focused on averaging over the cohort or subgroups; these scatterplots show the full
range of individual posterior relative effectiveness, as well as trends in age and previ-
ous birth consistent with Figures 6 and 7. The impact of age on relative effectiveness is
stronger than that of previous births, however, increase in each covariate decreases rela-
tive effectiveness. Table 2 provides detail on cohort characteristics by posterior relative
effectiveness, for women with estimates below 0.90, from 0.90–0.95, and above 0.95. Vi-
sualizing individual estimated relative effectiveness gives clinicians confidence that there
are not smaller subgroups of patients undetected by our subgroup analysis where relative
effectiveness is drastically lower.
Subgroup analysis has identified age and number of previous births as important co-
variates in predicting relative effectiveness. Partial dependence plots (Figure 10) give
average marginal effect of both predictors on relative effectiveness over gestational age.
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Figure 9: Individual posterior mean relative effectiveness by age (A) and number of pre-
vious births (B). Scatterplots show the full range of individual posterior relative effec-
tiveness as well as trends in age and previous birth consistent with Figures 6 and 7. The
impact of age on relative effectiveness is stronger than that of previous births, however,
increase in each covariate decreases relative effectiveness. There are only a handful of pa-
tients whose estimates for relative effectiveness are below 0.90. Table 2 provides detail on
cohort characteristics by posterior relative effectiveness, for women with estimates below
0.90, from 0.90–0.95, and above 0.95.
Gestational age is on the x-axis, with lines for age groups and previous number of births.
Panel A shows partial dependence of relative effectiveness on age over gestation, grouped
by the CART tree splits on age (Figure 7). Panel B shows partial dependence of relative
effectiveness on number of previous births. Plots support previous subgroup analysis
findings.
The early medical abortion analysis uses our suggested default parameter settings for
smoothness parameters (κµ = 1 and κτ = 1). We discuss parameter tuning in Section 3;
here, we perform a sensitivity analysis for robustness of our analysis to smoothness pa-
rameter choice. We let κµ=1 and fit the tsbcf model to the early medical abortion dataset
three times, with κτ ∈
{
1
3
, 1, 3
}
. These choices represent a three-times changes in magni-
tude in each direction, corresponding to varying the length-scale of the treatment trees’
covariance from one to three to nine.
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Figure 10: Partial dependence plots for covariates identified in subgroup analysis. These
are two-dimensional partial dependence plots, over the respective covariates and gesta-
tional age. Gestational age is on the x-axis, with lines for age groups and previous number
of births. (A) Partial dependence of relative effectiveness on age over gestation, grouped
by the CART tree splits on age (Figure 7). (B) Partial dependence of relative effectiveness
on number of previous births. Plots show that the marginal effect of both covariates are
consistent with the subgroup analysis.
Figure 11 plots the posterior mean relative effectiveness for three settings of the tsbcf
model’s smoothness parameter for the treatment tree fit. The solid line matches Figure
5, giving posterior relative effectiveness over gestational age with shaded 95% posterior
credible interval. The dashed lines corresponding to varying the κτ smoothness param-
eter. While there are small differences in the overall estimated relative effectiveness, we
do not see clinically meaningful variation from varying the smoothness, indicating that
our analysis is robust to smoothing parameter choice. We also note small differences in
the 9-week range of gestation, lending support to our intuition that the small increase at
9 weeks is due to small sample size.
Finally, in addition to helping clinicians provide better advice to each patient, clinics
must plan appropriately for potential adjustments in staffing and resource needs when
providing the simultaneous regimen as an option. To this end, we look at the treatment
effect on the treated – for patients who selected the simultaneous regimen and experi-
enced a failure, we plot the distribution of differences in the observed number of failures
under simultaneous compared to the expected failures had those patients selected inter-
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Figure 11: Posterior mean relative effectiveness for three settings of the tsbcf model’s
smoothness parameter for the treatment tree fit. The early medical abortion analysis was
performed using the recommended default smoothness parameter settings (1 for both
tree fits). The solid line matches Figure 1, giving posterior relative effectiveness over
gestational agewith shaded 95% posterior credible interval. We fit the same model twice
more, setting the treatment tree fit’s smoothness parameter κτ to 1/3 (‘’smoother”) and 3
(‘’wigglier”), reflecting shift in magnitude of three times in each direction. We do not see
clinically meaningful differences in the three posterior mean estimates across gestation,
indicating robustness to choice of smoothness parameter.
val over MCMC draws. We report this on the order of expected additional surgeries per
thousand patients, giving clinics a sense of the volume of likely additional procedures.
We find that a clinic can expect approximately 40–60 additional surgeries per thousand
patients (Figure 12).
6 Discussion
Our Targeted Smooth Bayesian Causal Forests model is a novel model which allows
for estimation of heterogeneous treatment effects which evolve smoothly over a target
covariate in the observational data setting. Targeted Smooth Bayesian Causal Forests en-
joys similar advantages to Bayesian Causal Forests: excellent recovery of heterogeneous
treatment effects in observational data, mitigation of biased treatment effect estimates via
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Figure 12: Distribution of differences in observed failure under the simultaneous protocol
versus expected failure under interval, for patients selecting simultaneous who experi-
enced failure. Clinics choosing to offer simultaneous administration may anticipate an
additional 40-60 surgeries per 1,000 patients treated.
separate regularization of the treatment tree fit, easily tunable hyperparameters, and no
need to specify a parametric forms of interactions. Tsbcf also benefits from the smooth-
ness over a single covariate provided by Gaussian Process priors, and has easily tunable
hyperparameters to control degree of smoothness via length-scale of the covariance func-
tions, leveraging the Targeted Smooth BART prior introduced by Starling et al. (2019).
Other hyperparameters are set efficiently using data-driven approaches as recommended
in Hahn et al. (2017) and Chipman et al. (2010). Additionally, like the previously men-
tioned BART-based methods, tsbcf handles is invariant to transformation of predictors,
categorical predictors seamlessly, and mitigates the curse of dimensionality via regular-
ization.
The analysis of relative effectiveness of the simultaneous medical abortion protocol
versus interval protocol represents a substantial advancement on previous work (Lohr
et al., 2018), in robust handling of potential confounding, smoothness over gestational
age, and assessing subgroups of patients with modest amounts of heterogeneity at later
gestational ages. We validate the results of Lohr et al. (2018) in that on average, we do not
see substantial decrease as gestationl progresses, only very modest decrease after seven
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Characteristic (N = 28,895) RE >0.95 (N = 21,304) RE 0.90-0.95 (N = 7,565) RE <.90 (N = 26) P-value
Gestational age in weeks, n (%) < 0.0001
4.5 407 (1.41) 407 (1.91) 0 (0.00) 0 (0.00)
5-5.5 4,917 (17.02) 4,917 (23.08) 0 (0.00) 0 (0.00)
6-6.5 9,453 (32.72) 8,430 (39.57) 1,023 (13.52) 0 (0.00)
7-7.5 7,875 (27.25) 4,583 (21.51) 3,291 (43.50) 1 (3.85)
8-8.5 5,577 (19.30) 2,605 (12.23) 2,947 (38.96) 25 (96.15)
9 666 (2.30) 362 (1.70) 304 (4.02) 0 (0.00)
Maternal age in years, n (%) < 0.0001
(11,20] 5,312 (18.38) 5,312 (24.93) 0 (0.00) 0 (0.00)
(20,30] 15,010 (51.95) 12,011 (56.38) 2,999 (39.64) 0 (0.00)
(30,40] 7,695 (26.63) 3,485 (16.36) 4,185 (55.32) 25 (96.15)
(40,53] 878 (3.04) 496 (2.33) 381 (5.04) 1 (3.85)
Maternal ethnicity, n (%) < 0.0001
Asian 2,610 (9.03) 1,941 (9.11) 669 (8.84) 0 (0.00)
Black 1,839 (6.36) 1,700 (7.98) 139 (1.84) 0 (0.00)
Not Reported 537 (1.86) 400 (1.88) 137 (1.81) 0 (0.00)
Other 1,568 (5.43) 1,165 (5.47) 402 (5.31) 1 (3.85)
White 22,341 (77.32) 16,098 (75.56) 6,218 (82.19) 25 (96.15)
BMI category (kg/m2), n (%) < 0.0001
Underweight (<18.5) 2,149 (7.44) 1,716 (8.05) 433 (5.72) 0 (0.00)
Normal (18.5-24.9) 14,667 (50.76) 10,878 (51.06) 3,769 (49.82) 20 (76.92)
Overweight (25.0-29.9) 7,367 (25.50) 5,179 (24.31) 2,182 (28.84) 6 (23.08)
Obese (>30.0) 4,712 (16.31) 3,531 (16.57) 1,181 (15.61) 0 (0.00)
Previous abortions, n (%) < 0.0001
0 18,354 (63.52) 14,373 (67.47) 3,980 (52.61) 1 (3.85)
1-2 9,876 (34.18) 6,546 (30.73) 3,306 (43.70) 24 (92.31)
3+ 665 (2.30) 385 (1.81) 279 (3.69) 1 (3.85)
Previous births, n (%) < 0.0001
0 18,354 (63.52) 14,373 (67.47) 3,980 (52.61) 1 (3.85)
1-2 5,070 (17.55) 3,071 (14.42) 1,989 (26.29) 10 (38.46)
3+ 5,471 (18.93) 3,860 (18.12) 1,596 (21.10) 15 (57.69)
Previous Cesarean cections, n (%) < 0.0001
0 18,354 (63.52) 14,373 (67.47) 3,980 (52.61) 1 (3.85)
1-2 1,346 (4.66) 801 (3.76) 545 (7.20) 0 (0.00)
3+ 9,195 (31.82) 6,130 (28.77) 3,040 (40.19) 25 (96.15)
Previous miscarriages: < 0.0001
0 18,354 (63.52) 14,373 (67.47) 3,980 (52.61) 1 (3.85)
1-2 2,046 (7.08) 1,082 (5.08) 948 (12.53) 16 (61.54)
3+ 8,495 (29.40) 5,849 (27.45) 2,637 (34.86) 9 (34.62)
Table 2: Descriptive characteristics by ranges of posterior mean individual relative effec-
tiveness. Relative effectiveness is divided into three columns: > 0.95, 0.90 − 0.95, and
< 0.90. P-values test for differences in distribution of patient characteristics between the
three ranges of relative effectiveness. Only 26 women (0.09%) have estimated relative ef-
fectiveness less than 0.90; all are over 30, and all but one have at least one previous birth.
Additionally, 21,304 women (74%) have estimated relative effectiveness greater than 0.95.
Women in the 0.90–0.95 category are also predominantly over 30.
weeks’ gestation to a degree which should not make clinicians uncomfortable recom-
mending the simultaneous regimen given its lower barriers to access. Our subgroup
identification expands on previous findings; while the simultaneous regimen remains
generally very effective, clinicians may wish to use our findings to inform advice to pa-
tients age 29 and greater who seek early medical abortion later in gestation (7–9 weeks),
particularly those with two or more previous births.
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One limitation of our work is the limited set of available covariates. It is plausible that
unobserved confounders exist, and our method regularizes to guard against this bias;
however, more demographic information about patients may inform subgroup analy-
sis. As described in Lohr et al. (2018), we do not know what covariates influenced each
woman’s choice in protocol. Women received counseling on the expected differences in
effectiveness and side effects based on a small pilot study conducted by British Pregnancy
Advisory Services. We do not know if or how counseling impacted women’s choice in
protocol, and aisde from clinicians’ use of a common comparison table in a printed client
guide, counseling is not standardized. Nonetheless, our work presents a clearer and more
nuanced picture of relative effectiveness of simultaneous administration of mifepristone
and misoprostol than previously available.
7 Supplemental Materials
The Targeted Smooth Bayesian Causal Forests R package tsbcf can be found at https:
//github.com/jestarling/tsbcf/.
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8 Appendix
A1. Fitting the tsbcf model.
Here we provide details on the model parameterization and prior for tsbcf. The model
is comprised of the sum of two tsBART fits, each with its own prior specification. The
model can be written in full as
yi = µ (ti, xi, pˆii) + τ (ti, xi) zi + i, i ∼ N(0, σ2) (23)
where the prognostic tsBART fit is parameterized as in Starling et al. (2019).
µ (ti, xi, pˆii) = ηµfµ(ti, xi, pˆii) ∼ tsBART
fµ(ti, xi, pˆii) =
200∑
j=1
gµ(ti, xi, pˆii;Tµj,Mµj), Mµj ∈ {m1j(t), . . . ,mbj(t)}
mhj ∼ GP(0, Cθµ(t, t′))
ηµ ∼ N(sµ, γ2)
γ2 ∼ IG(1
2
,
1
2
)
We calibrate the induced half-Cauchy prior’s median sµ by setting it equal to the twice
the marginal standard deviation of y. The variance of the squared exponential GP kernel
is set to 1/200, and smoothness parameter κµ = 1 governs the length-scale (Starling et al.,
2019). The prior on trees Tµj is as in Chipman et al. (2010), with depth penalty β = 2 and
split probability α = 0.95.
For the treatment effect fit, we parameterize to ensure the treatment effect is invariant
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to transformation, such that
τ (ti, xi) ∼ tsBART
τ (ti, xi) zi = [b1zi + b0 (1− zi)] fτ (ti, xi)
fτ (ti, xi) =
200∑
j=1
gτ (ti, xi, pˆii;Tτj,Mτj), Mτj ∈ {m1j(t), . . . ,mbj(t)}
mhj ∼ GP(0, Cθ(t, t′))
b1 ∼ N(sb
2
,
1
2
)
b0 ∼ N(−sb
2
,
1
2
)
This parameterization induces the prior b1 − b0 ∼ N(sb, 1) and we set sb to the marginal
median of y. The prior on trees Tτj uses depth penalty β = 3 and split probability α =
0.25. The variance of the squared exponential GP kernel is set to 1/50, and smoothness
parameter κτ = 1 governs the length-scale.
The prior for σ2 follows Chipman et al.’s recommendation for a rough over-estimation
of σˆ. We choose ν = 3 and q = 0.90, and estimate σˆ by regressing y onto x (including the
target variable as a covariate), then choose λ s.t. the qth quantile of the prior is located at
σˆ, i.e. P (σ ≤ σˆ) = q.
A2. Bayesian Backfitting Algorithm
We leverage the Bayesian backfitting MCMC algorithms of tsBART and bcf to design a
Bayesian backfitting algorithm for tsbcf. We refer interested readers to Chipman et al.
(2010) for a full discussion of the original Bayesian backfitting, and Starling et al. (2019)
and Hahn et al. (2017) for tsBART and bcf algorithms respectively. Briefly, Bayesian back-
fitting involves an MCMC algorithm where each tree, and its parameters are sampled
one at a time given the partial residuals from the other m − 1 trees. One iteration of the
sampler consists of looping through the trees, sampling each tree Tj via a Metropolis step,
and then sampling its associated leaf parametersMj , conditional on σ2 and the remaining
trees and leaf parameters. After a pass through all trees, σ2 is updated in a Gibbs step.
Updating trees and leaves
In general, to sample {Tj,Mj} conditioned on the other trees and leaf parameters
{
T(j),M(j)
}
,
define the partial residual as
rij = yi −
m∑
k=1,k 6=j
g(xi;Tk,Mk) . (24)
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Using rj as the working response vector, at step s of the MCMC one samples T
(s)
j by
proposing one of four local changes to T (s−1)j , marginalizing analytically over Mj . The
local change is selected randomly from the following candidates:
• grow randomly selects a terminal node and splits it into two child nodes
• prune randomly selects an internal node with two children and no grandchildren,
and prunes the children, making the selected node a leaf
• change randomly selects an internal node and draws a new splitting rule
• swap randomly selects a parent-child pair of internal nodes and swaps their deci-
sion rules
The change and swap moves are computationally expensive; in practice, BART is often
implemented with only prune and grow proposals (Pratola et al., 2014). Once the move in
tree space is either accepted or rejected, Mj is sampled from its Gaussian full conditional,
given Tj and σ2.
Distributional relationships
Our algorithm for fitting tsbcf retains the form of the method used in bcf, extended to the
multivariate setting as in tsBART. The following distributional relationships are useful for
deriving the full conditional distributions used in the backfitting updates.
• For µ(ti, xi, pˆi) the ”data” is
(
yi−[b1zi+b0(1−zi)]τ(ti,xi,pˆii)
ηµ
)
with variance
(
σ2
η2µ
)
• For τ(ti, xi, pˆi) the ”data” is
(
yi−ηµµ(ti,xi,pˆii)
[b1zi+b0(1−zi)]
)
with variance
(
σ2
[b1zi+b0(1−zi)]2
)
• For ηµ the ”data” is
∏n
i=1 N
(
yi−[b1zi+b0(1−zi)]τ(ti,xi,pˆi)
µ(ti,xi,pˆii)
∣∣∣ηµ, σ2µ(ti,xi,pˆii)2)
• For b1 the ”data” is
∏nz=1
i=1 N
(
yi−ηµµ(ti,xi,pˆii)
τ(ti,xi,pˆii)
∣∣∣b1, σ2τ(ti,xi,pˆii)2) for only the zi = 1 observa-
tions.
• For b0, same as b1, using only the zi = 0 observations.
Note that we use yi generally here; for updating tree and leaf parameters {Tµj,Mµj}
and {Tτj,Mτj} respectively, we are using the partial residuals with all other trees and leaf
parameters held constant as described above. For updating the prognostic fit µ(ti, xi, pˆi)
rij = yi −
200∑
k=1,k 6=j
g (xk;Tµk,Mµk)
and similarly, for updating the treatment fit τ(ti, xi, pˆi), the ‘’data” consist of the partial
residuals
rij = yi −
50∑
k=1,k 6=j
g (xk;Tτk,Mτk)
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Full conditionals
The posterior conditional distributions for the Bayesian backfitting algorithm are as fol-
lows. For simplicity we assume that target covariate values t are on a common discrete
grid, though this is not a requirement.
For updating (σ2|. . .), the prior, likelihood, and full conditional distributions are
• Prior:
p
(
σ2
) ∼ IG(ν
2
,
νλ
2
)
• Likelihood:
p
(
y
∣∣σ2) = n∏
i=1
N
(
yi | ηµµ (ti, xi, pˆii) + [b1zi + b0(1− zi)] τ (ti, xi, pˆii) , σ2
)
• Full conditional:
p (σ|. . .) ∼ IG
(
ν + n
2
,
∑n
i=1 (yi − yˆit) + νλ
2
)
.
For updating
(
γ2µ
∣∣. . .), the prior, likelihood, and full conditional distributions are
• Prior:
p(γ2µ) ∼ IG
(
1
2
,
1
2
)
,
• Likelihood:
p(ηµ | sµ, γ2µ) ∼ N
(
ηµ
∣∣sµ, γ2µ)
• Full conditional:
p(γ2µ | . . .) ∼ IG
(
1,
(ηµ − sµ)2 − 1
2
)
.
For updating (b1|. . .), the prior, likelihood, and full conditional distributions are
• Prior:
p(b1) ∼ N
(sb
2
, 1
)
,
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• Likelihood:
p(y | . . .) =
nz=1∏
i=1
N
(
ri − ηµµ(ti, xi, pˆii)
τ(ti, xi, pˆii)
∣∣∣∣b1, σ2τ(ti, xi, pˆii)2
)
,
• Full conditional:
p(b1 | . . .) ∼ N (m∗, v∗) , where
v∗ =
(
1
γ2b
+
1
σ2
nz=1∑
i=1
τ (ti, xi, pˆii)
2
)−1
and m∗ = v∗
(
sb
γ2b
+
1
σ2
nz=1∑
i=1
τ (ti, xi, pˆii)
2 ri
)
For updating (b0|. . .), the prior is p(b1) ∼ N
(− sb
2
, 1
)
, and the likelihood is computed
using the control observations, as opposed to treatment. The full conditional is then sim-
ilar to that of b1.
For updating (ηµ|. . .), the prior, likelihood, and full conditional distributions are
• Prior:
p(ην) ∼ N(sµ, γ2µ),
• Likelihood:
p(y | . . .) =
n∏
i=1
N
(
ri − [b1zi + b0 (1− zi)] τ(ti, xi, pˆii)
µ(ti, xi, pˆii)
∣∣∣∣ηµ, σ2µ(ti, xi, pˆii)2
)
• Full conditional:
p (ηµ|. . .) ∼ N (m∗, v∗) , where
v∗ =
(
1
γ2µ
+
∑n
i=1 µ (ti, xi, pˆii)
2
σ2
)−1
and m∗ = v∗
(
sµ
γ2µ
+
1
σ2
µ(ti, xi, pˆii)ri
)
For updating µ (ti, xi, pˆii) and τ (ti, xi), the priors are tsbcf; updates are performed
via the Bayesian backfitting algorithm, using the partial residuals as described previ-
ously. For updating prognostic trees Tµj , the marginal likelihood uses homogeneous vari-
ances, similar to the marginal likelihood in tsBART. For updating treatment trees Tτj , the
marginal likelihood is similar, but for heterogeneous variances. See the following sections
for further detail.
8.0.1 Marginal likelihood for prognostic tree updates
The marginal likelihood for updating the prognostic tree fits µ(ti, xi, pˆii) is the homo-
geneous version from BART with Targeted Smoothing. We derive the marginal log-
likelihood here for a single leaf. In the Backfitting algorithm, this is calculated for multiple
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leaves depending on whether a birth move or death move is proposed for the tree. The
likelihoods are then used in calculating the acceptance probability for the Metropolis step.
Let yl represent the length nl vector of residuals for a given leaf. Let Tµj be the tree
structure for the jth tree, and tlen be the length of the grid of unique target values. We
integrate out leaf means vector ml to obtain the marginal log-likelihood as follows.
p(yl|Tj, σ2) =
∫
R
Nnl
(
yl
∣∣Wlml, σ2I) ·Ntlen (ml|m0,Σ0) ∂ml
whereWl is a n×tlen matrix, with one row for each observation; all entries are zero, except
a 1 in the column corresponding to each observation i’s associated time ti. Set m0 = 0.
The marginal log-likelihood is then
p(yl|Tµj, σ2) = −nl
2
log
(
2piσ2
)
+
1
2
log (|K|)− 1
2
log (|C|)− 1
2
[
1
σ2
yTl yl + µ
T
0Kµ0 − bTC−1b
]
where C =
(
1
σ2
W Tl Wl +K
)
and b =
(
1
σ2
W Tl yl +Km0
)
. For computational purposes,
W Tl Wl =
[
n1 ... ntmax
]
, the vector of sample sizes for each time. In addition, yTl yl =
∑nl
i=1 yi,
the sum of all yi in leaf l.
8.0.2 Marginal likelihood for treatment tree updates
The marginal likelihood for updating treatment fits is slightly more complex. We need the
marginal log-likelihood in the case of heterogeneous variances. Recall that for updating
τ(ti, xi, pˆii), the variance is
(
σ2
[b1zi+b0(1−zi)]2
)
, which is unique for each observation.
Let yl represent the length nl vector of residuals for a given leaf. Let Tτj be the tree
structure for the jth tree. We integrate out leaf means vector ml to obtain the marginal
log-likelihood as follows. Instead of σ2I = (ωI)−1, use the (nl × nl) precision matrix
Λ = diag [ω1, . . . , ωnl ].
We integrate out leaf means vectorml to obtain the marginal log-likelihood as follows.
p(yl|Tτj, σ2) =
∫
R
Nnl
(
yl
∣∣Wlml,Λ−1) ·NT (ml∣∣m0, K−1) ∂ml
where Wl is gain a n× tlen matrix, with one row for each observation; all entries are zero,
except a 1 in the column corresponding to each observations i’s associated time ti. We
again let µ0 = 0. The marginal log-likelihood is then
p(yl|Tτj, σ2) = −nl
2
log (2pi) +
1
2
[
log (|Λ|) + log (|K|)− log (|C|)− [yTl Λyl − bTC−1b]]
whereC =
(
W Tl ΛWl +K
)
and b =
(
W Tl Λyl +Kµ0
)
. For computational purposes,W Tl ΛWl
is the the tlen × tlen diagonal matrix of sums of precisions for each sample size. W Tl Λyl is
the vector of ωiyi sums for each time point, and yTl Λyl =
∑nl
i=1 ωiy
2
i . Finally, log (|Λ|) =∑nl
i=1 log (ωi)
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